Treprostinil is under clinical development by United Therapeutics and currently in Phase III for Idiopathic Pulmonary Fibrosis.

Ralinepag XR is under clinical development by United Therapeutics and currently in Phase III for Pulmonary Arterial Hypertension.

Increasing average concentrations of sotatercept improved 6-minute walk distance, pulmonary vascular resistance, and levels of NT-proBNP.

In this article, we will be taking a look at the 12 cheap healthcare stocks to buy heading into 2025.

[1] E. C. Rizos, E. E. Ntzani, E. Bika, M. S. Kostapanos and M. S. Elisaf, “Association between Omega-3 Fatty Acid Supplementation and Risk of Major Cardiovascular ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Specific tools in the treatment of PPHN include modern ventilatory strategies, inhaled nitric oxide, sildenafil, prostacyclin and extracorporeal membrane oxygenation. Rarely will a cardiac lesion be ...

We recently compiled a list of the 12 Cheap Healthcare Stocks to Buy Heading into 2025. In this article, we are going to take ...

We recently compiled a list of the 12 Cheap Healthcare Stocks to Buy Heading into 2025. In this article, we are going to take ...

The Odessa American is the leading source of local news, information, entertainment and sports for the Permian Basin.

United Therapeutics is also in search of an effective medicine with trepostinil, a prostacyclin mimetic, currently in phase 3 development for IPF. As is Bristol-Myers Squibb, recently announcing ...

FDA experts report changes in drug approvals, warnings, and indications for products for use by dermatologists and aesthetic medicine professionals.